Alexion Pharma (ALXN) Announces Restructuring, Including Workforce Reduction of 20%

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. ZS
3. PENG
4. STZ
5. MSFT
6. NVDA
7. SPY
8. SKYD
9. IBM
10. CRWV

Go back to Alexion Pharma (ALXN) Announces Restructuring, Including Workforce Reduction of 20%

Alexion Announces Restructuring to Advance Corporate Strategy

September 12, 2017 8:00 AM EDT

Expect to Deliver Approximately $270 Million in GAAP and Approximately $250 Million in Non-GAAP Pre-tax Savings Annually by 2019 Global Workforce Reduction of Approximately 20% Expect to Reinvest Approximately $100 Million Annually to Build Pipeline Through Disciplined Business Development and Additional Complement Indications Maximize Leadership in Complement and Grow Rare Disease Business by Focusing Investments in Priority Growth Areas Research Center of Excellence to be Based in New Haven, CT New Headquarters in Boston, MA to Support Innovation and Future Growth... More

Alexion to Host Call to Discuss Restructuring to Advance Corporate Strategy at 8:30 a.m. on September 12, 2017

September 11, 2017 4:15 PM EDT

NEW HAVEN, Conn.--(BUSINESS WIRE)-- Alexion Pharmaceuticals (Nasdaq: ALXN) today announced that the Company will issue a press release on its restructuring to advance its corporate strategy on Tuesday, September 12, 2017 at 8:00 a.m. ET. Following the release, Alexion management will conduct a... More